1[1]Zimmerman j,Fromm R,Meyer D,et al.Diagnosticmarker cooperative study for the diagonosis of myocardial infarcion.Circulation,1999,99:1671-1677.
2[2]Chobanian AV,Lille RD,Tercyak,A,et al The metabolic and hemodynamic effects of prolonged bed rest in normal subjects.Circulation,1974,49:551-559.
3[3]Winsiow EH.Cardiovascular conscquences of bed rest.Heart Lung,1985,14:236-246.
4[4]Yusuf S,Peto R,Llewis J,et al.Beta blockade during and after myocardial infarction:anoverview of the randomized trials.Prog Cardiovase Dis,1985,27:335-371.
5[5]The TIMI Study Group.Comparison of invasive and conservative strategies after treatment with intravenous tissue plasmmogen activator in acute myocardial infarctionresults of the thrombolysis in myocardial infarction(TIMI) phase Ⅱ trial.N Engl J Med,1989,320:618-627.
6[6]Furberg CD,Psaty BM,Mayer JV.Nifedipinc:dose-related increase in mortality in patients with coronary heart disease.Circulation,1995,92:1326-1331.
7[7]Fibrinolytic Therapy Trialists,(FTT)Collaborative Group.Indications for fibrinolytic therapy in suspeeted acute cyocardial infarction,collaborative overview of early mortality and major morbidity results from all randomized trials of more than 100 patients.Lancet,1994,343,311-322.
8[8]Carmon CP,McCabe CH,Diver DJ,et al.Comparison of front-loaded recombinant tissuetype plasminogen activator,anistreplase and combination thrombolytic therapy for acute myocardial infarction results of the Thrombolysis in Myocardial Infarction(TIMI) 4 trial.J Am Coll Cardiol,1994,24:1602-1610.
9[9]Effects of tissue plasminogen activator and a comparison of carly invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction results of the TIMI ⅢB Trial.Thrombolysis in Myocardial Ischemia.Circulation,1994,89:1545-1556.
